Metagenomi Inc [NASDAQ: MGX] gained 3.73% or 0.06 points to close at $1.67 with a heavy trading volume of 262662 shares.
It opened the trading session at $1.64, the shares rose to $1.6854 and dropped to $1.62, the range by which the price of stock traded the whole day. The daily chart for MGX points out that the company has recorded -52.56% loss over the past six months.
If we look at the average trading volume of 452.19K shares, MGX reached to a volume of 262662 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Metagenomi Inc [MGX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MGX shares is $10.75 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MGX stock is a recommendation set at 1.33. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Metagenomi Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on May 07, 2024. While these analysts kept the previous recommendation, JP Morgan raised their target price from $16 to $6. The new note on the price target was released on May 02, 2024, representing the official price target for Metagenomi Inc stock. Previously, the target price had yet another raise to $25, while Wells Fargo analysts kept a Overweight rating on MGX stock.
The Price to Book ratio for the last quarter was 0.29, with the Price to Cash per share for the same quarter was set at 6.05.
Trading performance analysis for MGX stock
Metagenomi Inc [MGX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 5.03. With this latest performance, MGX shares dropped by -5.65% in over the last four-week period, additionally sinking by -52.56% over the last 6 months – not to mention a drop of -53.74% in the past year of trading.
Metagenomi Inc [MGX]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Metagenomi Inc [MGX] shares currently have an operating margin of -193.73% and a Gross Margin at 87.87%. Metagenomi Inc’s Net Margin is presently recorded at -172.21%.
Return on Equity for this stock declined to -21.86%, with Return on Assets sitting at -21.86%.
Metagenomi Inc [MGX]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MGX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Metagenomi Inc go to -14.66%.
An analysis of Institutional ownership at Metagenomi Inc [MGX]
There are presently around $26.49%, or 36.90% of MGX stock, in the hands of institutional investors. The top three institutional holders of MGX stocks are: NOVO HOLDINGS A/S with ownership of 1.8 million shares, which is approximately 4.9146%. RA CAPITAL MANAGEMENT, L.P., holding 1.48 million shares of the stock with an approximate value of $$6.03 million in MGX stocks shares; and RA CAPITAL MANAGEMENT, L.P., currently with $$5.48 million in MGX stock with ownership which is approximately 3.6674%.
